1
|
Hawkins BA, Adair LD, Ryder WG, Du JJ, Najib E, New EJ, Gale PA, Platts JA, Groundwater PW, Hibbs DE. Influence of Halogen Substituents on the Photophysical Properties of 7-Hydroxycoumarin: Insights from Experimental and Theoretical Studies. Chemphyschem 2024:e202400812. [PMID: 39615052 DOI: 10.1002/cphc.202400812] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2024] [Revised: 11/29/2024] [Indexed: 12/13/2024]
Abstract
The benzopyrone molecule coumarin is a popular fluorescent scaffold, but how chemical modifications affect its properties is not well understood. We investigated this using halogenated 7-hydroxycoumarin, unsubstituted 4-methylumbiliferone, and ortho-chloro and bromo substitutions on the phenolic ring. Charge density data from X-Ray diffraction and computational methods revealed that halogenation at the ortho position significantly reduced quantum yield (QY). Specifically, 7-hydroxycoumarin (1) had a QY of 70 %, while ortho-chloro (2) and ortho-bromo (3) had QYs of 61 % and 30 %, respectively. Experimental data showed that these molecules excited similarly, but the electrostatic potential and dipole moments indicated that 2 and 3 dissipated excitation energy more easily due to charge separation. The heavy-atom effect of Cl and Br did not fully explain the QY reductions, suggesting other radiative decay processes were involved. By incorporating spin-orbit coupling (SOC) effects, we estimated intersystem crossing (ISC) and phosphorescence rates, providing theoretical QYs of 78 % for 1, 59 % for 2, and 15 % for 3. The large deviation for 3 was attributed to its higher SOC potential derived in computational calculations. Our overall findings indicate that 3's reduced QY results from a mix of SOC-induced ISC and charge dissipation due to the electronegativity of Br atom, while 2's reduction is primarily due to charge separation caused by Cl alone. Further studies are needed to validate this approach with other scaffolds.
Collapse
Affiliation(s)
- Bryson A Hawkins
- Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, NSW, 2006, Australia
- Current Address: Antimicrobial Discovery Centre, College of Science, Northeastern University, Boston, MA, 02115, USA
| | - Liam D Adair
- School of Chemistry, Faculty of Science, The University of Sydney, NSW, 2006, Australia
- Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney, NSW, 2006, Australia
| | - William G Ryder
- School of Chemistry, Faculty of Science, The University of Sydney, NSW, 2006, Australia
| | - Jonathan J Du
- Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, NSW, 2006, Australia
| | - Elias Najib
- Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, NSW, 2006, Australia
| | - Elizabeth J New
- School of Chemistry, Faculty of Science, The University of Sydney, NSW, 2006, Australia
- Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney, NSW, 2006, Australia
| | - Philip A Gale
- Faculty of Science, University of Technology Sydney, City Campus, Broadway, NSW, 2007, Australia
- School of Chemistry, Faculty of Science, The University of Sydney, NSW, 2006, Australia
| | - James A Platts
- School of Chemistry, Cardiff University, Cardiff, CF10 3AT, UK
| | - Paul W Groundwater
- Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, NSW, 2006, Australia
| | - David E Hibbs
- Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, NSW, 2006, Australia
| |
Collapse
|
2
|
Lippe D, Elghawy O, Zucker AM, Yanagawa ESK, Mathews E, Ahmed YG, D’Elia PN, Bimson S, Walvoord RR. Synthesis of 7-Aminocoumarins from 7-Hydroxycoumarins via Amide Smiles Rearrangement. ACS OMEGA 2022; 7:35269-35279. [PMID: 36211046 PMCID: PMC9535735 DOI: 10.1021/acsomega.2c04653] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/22/2022] [Accepted: 09/05/2022] [Indexed: 06/16/2023]
Abstract
N-Substituted 7-aminocoumarins can be synthesized from readily available 7-hydroxycoumarins via alkylation with α-bromoacetamides and subsequent tandem O → N Smiles rearrangement-amide hydrolysis. The key rearrangement sequence proceeds under mild conditions to provide convenient access to various N-alkyl and N-aryl products in moderate to high yields. The process is operationally simple, inexpensive, transition-metal-free, and can be telescoped into a one-pot process.
Collapse
|
3
|
Koga H, Negishi M, Kinoshita M, Fujii S, Mori S, Ishigami-Yuasa M, Kawachi E, Kagechika H, Tanatani A. Development of Androgen-Antagonistic Coumarinamides with a Unique Aromatic Folded Pharmacophore. Int J Mol Sci 2020; 21:ijms21155584. [PMID: 32759847 PMCID: PMC7432827 DOI: 10.3390/ijms21155584] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2020] [Revised: 07/31/2020] [Accepted: 07/31/2020] [Indexed: 01/06/2023] Open
Abstract
First-generation nonsteroidal androgen receptor (AR) antagonists, such as flutamide (2a) and bicalutamide (3), are effective for most prostate cancer patients, but resistance often appears after several years due to the mutation of AR. Second-generation AR antagonists are effective against some of these castration-resistant prostate cancers, but their structural variety is still limited. In this study, we designed and synthesized 4-methyl-7-(N-alkyl-arylcarboxamido)coumarins as AR antagonist candidates and evaluated their growth-inhibitory activity toward androgen-dependent SC-3 cells. Coumarinamides with a secondary amide bond did not show inhibitory activity, but their N-methylated derivatives exhibited AR-antagonistic activity. Especially, 19b and 31b were more potent than the lead compound 7b, which was comparable to hydroxyflutamide (2b). Conformational analysis showed that the inactive coumarinamides with a secondary amide bond have an extended structure with a trans-amide bond, while the active N-methylated coumarinamides have a folded structure with a cis-amide bond, in which the two aromatic rings are placed face-to-face. Docking study suggested that this folded structure is important for binding to AR. Selected coumarinamide derivatives showed AR-antagonistic activity toward LNCaP cells with T877A AR, and they had weak progesterone receptor (PR)-antagonistic activity. The folded coumarinamide structure appears to be a unique pharmacophore, different from those of conventional AR antagonists.
Collapse
Affiliation(s)
- Hitomi Koga
- Department of Chemistry, Faculty of Science, Ochanomizu University, 2-1-1 Otsuka, Bunkyo-ku, Tokyo 112-8610, Japan; (H.K.); (M.N.); (M.K.)
| | - Mai Negishi
- Department of Chemistry, Faculty of Science, Ochanomizu University, 2-1-1 Otsuka, Bunkyo-ku, Tokyo 112-8610, Japan; (H.K.); (M.N.); (M.K.)
| | - Marie Kinoshita
- Department of Chemistry, Faculty of Science, Ochanomizu University, 2-1-1 Otsuka, Bunkyo-ku, Tokyo 112-8610, Japan; (H.K.); (M.N.); (M.K.)
| | - Shinya Fujii
- Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), 2-3-10 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-0062, Japan; (S.F.); (S.M.); (M.I.-Y.); (E.K.)
| | - Shuichi Mori
- Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), 2-3-10 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-0062, Japan; (S.F.); (S.M.); (M.I.-Y.); (E.K.)
| | - Mari Ishigami-Yuasa
- Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), 2-3-10 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-0062, Japan; (S.F.); (S.M.); (M.I.-Y.); (E.K.)
| | - Emiko Kawachi
- Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), 2-3-10 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-0062, Japan; (S.F.); (S.M.); (M.I.-Y.); (E.K.)
| | - Hiroyuki Kagechika
- Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), 2-3-10 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-0062, Japan; (S.F.); (S.M.); (M.I.-Y.); (E.K.)
- Correspondence: (H.K.); (A.T.); Tel.: +81-3-5280-8032 (H.K.); +81-3-5978-2716 (A.T.)
| | - Aya Tanatani
- Department of Chemistry, Faculty of Science, Ochanomizu University, 2-1-1 Otsuka, Bunkyo-ku, Tokyo 112-8610, Japan; (H.K.); (M.N.); (M.K.)
- Institute of Human Life Innovation, Ochanomizu University, 2-1-1 Otsuka, Bunkyo-ku, Tokyo 112-8610, Japan
- Correspondence: (H.K.); (A.T.); Tel.: +81-3-5280-8032 (H.K.); +81-3-5978-2716 (A.T.)
| |
Collapse
|
4
|
Janicki I, Kiełbasiński P. Still–Gennari Olefination and its Applications in Organic Synthesis. Adv Synth Catal 2020. [DOI: 10.1002/adsc.201901591] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Affiliation(s)
- Ignacy Janicki
- Division of Organic ChemistryCentre of Molecular and Macromolecular Studies, Polish Academy of Sciences Sienkiewicza 112 90-363 Łódź Poland
| | - Piotr Kiełbasiński
- Division of Organic ChemistryCentre of Molecular and Macromolecular Studies, Polish Academy of Sciences Sienkiewicza 112 90-363 Łódź Poland
| |
Collapse
|